Journal
Regulatory
What changed, what it means and what to do about it.
The FDA just voted on seven peptides. Here’s what actually changed.
Six of seven peptides — BPC-157, TB-500, KPV, MOTS-c, Semax, Epitalon — got favorable PCAC votes. What that does and doesn’t change for your program.
ReadThe DEA extended telemedicine prescribing again. Here’s the 2026 map.
Controlled-substance telehealth stays lawful through December 31, 2026 — and the permanent special-registration framework is visible in outline. What to rely on and what to build.
Read2 posts in Regulatory
By email
Get new guides in your inbox
A couple of posts a week on building and running care programs. Unsubscribe any time.
Subscribe to the Journal
No spam, and no sales sequences.
Get started
Put a medical practice behind your product
Book a call and we'll scope your program together, or get free sandbox access and start building.